State Street SPDR S&P Biotech ETF (XBI)
NYSEARCA: XBIState Street Investment ManagementHealthETFUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
XBI chart
Full chartKey facts
- Expense ratio
- 0.35%
- Assets (AUM)
- $10.36B
- Dividend yield
- 0.35%
- Holdings
- 10
- Inception
- Jan 31, 2006
- Issuer
- State Street Investment Management
- Index tracked
- —
- Category
- Health
- 52-week range
- 103.43 – 169.89
- Volume / Avg
- 9.53M / 8.60M
- Beta
- —
- Previous close
- 150.90
XBI ETF today
The State Street SPDR S&P Biotech ETF (XBI) is an exchange-traded fund from State Street Investment Management in the Health category. It charges an expense ratio of 0.35%, or $35.00 per year on a $10,000 investment, and manages $10.36 billion in assets. Its largest holding is Twist Bioscience Corp (TWST) at 2.21% of assets, and the top 10 positions make up 16.7% of the portfolio out of 10 holdings.
XBI is up 23.2% year to date and has gained 44.9% over the past 12 months; over five years its price has changed +20.1%. The fund's trailing dividend yield is 0.35%. XBI launched on Jan 31, 2006.
Summary generated from market data by MetaCap's automated system. Methodology
XBI top 10 holdings
| # | Holding | Weight |
|---|---|---|
| 1 | TWSTTwist Bioscience Corp | 2.21% |
| 2 | MRNAModerna Inc | 2.04% |
| 3 | NTRANatera Inc | 1.80% |
| 4 | IOVAIovance Biotherapeutics Inc | 1.62% |
| 5 | AMGNAmgen Inc | 1.55% |
| 6 | BIIBBiogen Inc | 1.54% |
| 7 | UTHRUnited Therapeutics Corp | 1.54% |
| 8 | ABBVAbbVie Inc | 1.50% |
| 9 | HALOHalozyme Therapeutics Inc | 1.48% |
| 10 | SYRESpyre Therapeutics Inc | 1.47% |
Top 10 holdings: 16.7% of assets.
XBI performance
1 week
-4.72%
1 month
-7.23%
3 months
-7.82%
6 months
+14.99%
Year to date
+23.21%
1 year
+44.90%
3 years
+115.85%
5 years
+20.11%
XBI price return, excluding dividends.
ETFs similar to XBI
XBI news
All XBI newsXBI ETF FAQ
What is the XBI price today?
XBI last traded at $150.23 as of Oct 7, 4:00 PM EDT, down 0.44% on the day.
What is XBI's expense ratio?
XBI has an expense ratio of 0.35%, which works out to about $35.00 per year for every $10,000 invested.
What are XBI's top holdings?
XBI's largest holdings are Twist Bioscience Corp (2.21%), Moderna Inc (2.04%), Natera Inc (1.80%), Iovance Biotherapeutics Inc (1.62%), Amgen Inc (1.55%). The top 10 make up 16.7% of the fund.
Does XBI pay a dividend?
Yes. XBI has a trailing dividend yield of 0.35% and pays semiannual distributions; the most recent was $0.138 per share with an ex-dividend date of Jun 22, 2026.
How big is XBI?
XBI has about $10.36 billion in assets under management spread across 10 holdings.